SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT06208748 |
|
Recruitment Status :
Not yet recruiting
First Posted : January 17, 2024
Last Update Posted : May 20, 2024
|
Sponsor:
Sarcoma Alliance for Research through Collaboration
Collaborators:
Cogent Biosciences, Inc.
Dana-Farber Cancer Institute
The Life Raft Group
Information provided by (Responsible Party):
Sarcoma Alliance for Research through Collaboration
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Not yet recruiting |
|---|---|
| Estimated Primary Completion Date : | March 2026 |
| Estimated Study Completion Date : | March 2027 |